The findings obtained in this investigation indirectly concur with the observations made with the intravenous application of cetuximab in patients undergoing therapy of metastatic colorectal cancer or advanced squamous cell carcinoma of head and neck with EGFR expression13,14. The gene discussed is EGFR; the disease is metastatic colorectal cancer.